Objective and design: This study was undertaken to evaluate the anti-inflammatory effect of the pure compound salicin on dextran sulfate sodium (DSS)-induced colitis in a mouse model and to quantify the major gut bacteria during the treatment. Material or subjects: Experimental colitis was induced in Swiss albino mice by dissolving 2 % DSS in their drinking water for 7 days. Five mice were used in each group. Treatment: Salicin (100 and 200 mg per body weight) was administered daily through oral gavage for 7 days. Methods: Disease activity index (DAI), colon length, myeloperoxidase (MPO) assay, pro-inflammatory cytokine expression, histological changes and absolute number of gut microbiota were measured after treatment. Student's t test was applied for statistical analysis. Results: Salicin significantly attenuated DSS-induced DAI scores, shortening of colon length and tissue MPO activity. Salicin administration also effectively and dose-dependently prevented pro-inflammatory cytokine expression in DSS-induced colitis mice. Histological examination indicated that salicin suppressed edema, mucosal damage and the loss of crypts induced by DSS. Oral administration of salicin in DSS-treated mice prevented loss of gut microbiota during the short period of treatment. Conclusions: Salicin has an anti-inflammatory effect, and it may have therapeutic value in ameliorating inflammation during colitis.
|Number of pages||9|
|State||Published - Feb 2014|
Bibliographical noteFunding Information:
Acknowledgments NV is thankful to the Council of Scientific and Industrial Research, New Delhi for the research fellowship for conducting the study. This work was supported partially by the funding received by JP from CSIR, UGC Resource networking funds, New Delhi during the investigation. The authors are also thankful to the animal house, JNU, New Delhi for providing experimental mice for the above study.
- Dextran sodium salt
- Disease activity index
- Gut microbiota
ASJC Scopus subject areas